KIM
48
-6
USB
39
2
UA
29
-4
ADI
56
-6
VRSK
59
21
FMC
39
-2
KEY
37
3
EXR
46
6
BLK
57
3
DFS
56
-6
ADP
62
4
RRC
62
-6
FOX
35
2
CLX
43
-7
MSI
52
2
NI
50
2
AMT
56
5
WDC
55
-2
SBUX
27
-17
EQIX
54
-5
KIM
48
-6
USB
39
2
UA
29
-4
ADI
56
-6
VRSK
59
21
FMC
39
-2
KEY
37
3
EXR
46
6
BLK
57
3
DFS
56
-6
ADP
62
4
RRC
62
-6
FOX
35
2
CLX
43
-7
MSI
52
2
NI
50
2
AMT
56
5
WDC
55
-2
SBUX
27
-17
EQIX
54
-5
Financhill
Back

Astria Therapeutics Stock Predictions

MarketBeat Alert: Strong sell signal just issued for these 20 stocks

Go here now to get free instant access to all 20 stocks to sell.
Sell
23

ATXS
Astria Therapeutics

Last Price:
9.50
Seasonality Move:
-21.49%

7 Day Trial

ALL ACCESS PASS

$ 7

MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold

The result is a select group of high-quality blue-chip stocks.

Astria Therapeutics Stock Forecast

  • Over the next 52 weeks, Astria Therapeutics has on average historically fallen by 20.3% based on the past 8 years of stock performance.
  • Astria Therapeutics has fallen lower in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Astria Therapeutics Stock Undervalued?
    The current Astria Therapeutics [ATXS] share price is $9.50. The Score for ATXS is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ATXS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Astria Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Astria Therapeutics has on average historically fallen by 20.3% based on the past 8 years of stock performance.

Astria Therapeutics Stock Rating

Sell
23
Astria Therapeutics (ATXS) is a Sell

Is Astria Therapeutics overpriced?

  • Astria Therapeutics has fallen lower in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Astria Therapeutics Stock Price History

Is ATXS stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATXS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
astriatx.com

52-Week Data

52-Week High:
16.90
52-Week Low:
4.26

Prediction Charts

Market Cap:
521.58M
Price in USD:
9.50
Volume:
2.65M
Beta:
1.04

Technical Analysis

SMA50:
12.72
SMA100:
11.06
SMA200:
9.01
52-Wk Change:
-30.76%

Stock Predictions

  • Is Astria Therapeutics stock public?
    Yes, Astria Therapeutics is a publicly traded company.
  • What is the Astria Therapeutics stock quote today?
    The Astria Therapeutics stock price is 9.50 USD today.
  • How to buy Astria Therapeutics stock online?
    You can buy Astria Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-12 11.12 10.81 11.33 10.50
Apr-15 10.84 10.89 11.12 10.57
Apr-16 10.79 11.10 11.33 10.76
Apr-17 11.18 10.55 11.29 10.46
Apr-18 10.45 10.55 10.87 10.43
Apr-19 10.42 9.75 10.64 9.48
Apr-22 9.86 9.80 10.01 9.53
Apr-23 9.65 9.63 9.97 9.51
Apr-24 9.74 9.00 9.78 8.93
Apr-25 8.83 9.17 9.19 8.77
Apr-26 9.18 9.00 9.46 8.97
Apr-29 9.08 9.15 9.46 8.99
Apr-30 9.08 9.18 9.29 9.01
May-1 9.15 9.50 9.83 9.02

Astria Therapeutics Earnings

Astria Therapeutics Earnings Report: Per Share Astria Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Astria Therapeutics Forecast Revenue Growth

Astria Therapeutics Stock Analysis: Historical quarterly revenues per share for Astria Therapeutics and historical quarterly revenue growth:

* Astria Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.